Scarica l'app Stockscreener
2.19
5.29%
0.11
Precedente Chiudi:
$2.08
Aprire:
$2.1
Volume 24 ore:
2.42M
Relative Volume:
2.44
Capitalizzazione di mercato:
$201.22M
Reddito:
-
Utile/perdita netta:
$-30.15M
Rapporto P/E:
-2.4066
EPS:
-0.91
Flusso di cassa netto:
$-31.63M
1 W Prestazione:
+42.21%
1M Prestazione:
+93.81%
6M Prestazione:
+160.40%
1 anno Prestazione:
+140.61%
Intervallo 1D:
$1.98
$2.28
Intervallo di 1 settimana:
$1.52
$2.28
Portata 52W:
$0.49
$2.28
Context Therapeutics Inc Stock (CNTX) Company Profile
Nome
Context Therapeutics Inc
Settore
Industria
Telefono
267-225-7416
Indirizzo
2001 MARKET STREET, PHILADELPHIA
Confronta CNTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
2.19 | 191.11M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Guggenheim | Buy |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2025-01-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-11-25 | Iniziato | D. Boral Capital | Buy |
| 2024-05-16 | Iniziato | Piper Sandler | Overweight |
Context Therapeutics Inc Borsa (CNTX) Ultime notizie
Savara Grants Equity Awards to New Hires as It Advances Rare Lung Drug - mychesco.com
How does Context Therapeutics Inc compare to its peersWeekly Loss Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Sarepta Therapeutics, Inc. (SRPT) stock: surges after-hours ahead of key Phase 3 results webcast - parameter.io
Context Therapeutics Insiders May Regret Not Buying More, Market Cap Hits US$151m - simplywall.st
AI Stocks: Can TRTX deliver consistent dividendsJuly 2025 Institutional & Entry Point Confirmation Signals - baoquankhu1.vn
Context Therapeutics (NASDAQ: CNTX) Issues Equity Awards to Attract New Talent - mychesco.com
Aug PostEarnings: Is Context Therapeutics Inc. likely to announce a buyback2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks - Finviz
Sandoz Group (OTCMKTS:SDZNY) versus Context Therapeutics (NASDAQ:CNTX) Head-To-Head Contrast - Defense World
emerging us stocks2025 Price Targets & Verified Technical Trade Signals - bollywoodhelpline.com
Ideas Watch: How does Context Therapeutics Inc perform in inflationary periodsMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - Barchart.com
Contineum Therapeutics Reports Phase 2 Trial Results - MSN
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Analysts Are Bullish on Top Healthcare Stocks: Climb Bio (CLYM), Travere Therapeutics (TVTX) - The Globe and Mail
CEO Moves: Can Context Therapeutics Inc. stock double in the next year2025 Market Sentiment & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Revenue Check: Does Consensus Cloud Solutions Inc stock trade at a discount to peers2025 Volume Leaders & Stock Timing and Entry Methods - Bộ Nội Vụ
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Context Therapeutics Welcomes Andy Pasternak as New Chairman of the Board - MSN
Will Context Therapeutics Inc. stock benefit from automationPortfolio Gains Summary & Risk Adjusted Swing Trade Ideas - Улправда
Context Therapeutics Inc.Common Stock (NQ: CNTX - FinancialContent
User | inyoregister.comContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Pasadena Star News - FinancialContent
Moving Average Crossover Confirms Uptrend in Manugraph India LimitedFederal Reserve Announcements & Breakout Portfolio Performance - bollywoodhelpline.com
About Us - FinancialContent
Can Context Therapeutics Inc. stock hit record highs againWeekly Earnings Recap & Weekly Top Stock Performers List - Улправда
Will Theranexus Société Anonyme (3VG) stock beat value stocks2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Why Context Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Weekly Breakout Watchlists - Улправда
Why Context Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Sentiment & Daily Profit Maximizing Tips - Улправда
Dow Theory LettersContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Will Enliven Therapeutics Inc. stock see insider buyingWeekly Stock Report & AI Forecasted Stock Moves - ulpravda.ru
Context Therapeutics Highlights T Cell Engager Pipeline Strategy - TipRanks
Context Therapeutics Inc Updates Corporate Presentation on T Cell Engagers - TradingView — Track All Markets
Why Context Therapeutics Inc. stock remains on buy listsGrowth Stock Opportunities & Fast Profit Trading Tips - ulpravda.ru
ALNA pre-market +3.16% on 252,311,606 shares 06 Jan 2026: check catalysts - Meyka
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - Nasdaq
Wondering what's happening in today's after-hours session? - Chartmill
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 UpsideDVLT, UFG, VRME, ARBE More Inside - openPR.com
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside - FinancialContent
Uni-Fuels Holdings Limited (UFG) Stock, Price, News, Quotes, Forecast and Insights - MSN
Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside In Biotech Innovation - DirectorsTalk Interviews
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
MACD Signals Flash Warning for CRP Risk Management Limited StockAnalyst Upgrades & High Yield Portfolio Growth - bollywoodhelpline.com
Raconteur Global Resources Limited Inches Toward Key Resistance — Will It BreakChart Pattern Recognition & Small Budget Wealth Building - bollywoodhelpline.com
BDH Industries Limited Building a Base Near SupportHead and Shoulders Patterns & High Profit Trading Alerts - bollywoodhelpline.com
MACD Signals Flash Warning for Sagar Diamonds Limited StockEarnings Beat Highlights & Free Stock Price Trend Analysis - bollywoodhelpline.com
Jones Trading Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq
Context Therapeutics (NASDAQ:CNTX) Coverage Initiated by Analysts at Jones Trading - MarketBeat
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Context Therapeutics Inc Azioni (CNTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):